GENEVA, April 14 -- SULIS THERAPEUTICS APS (Inge Lehmanns Gade 108000 Aarhus C) filed a patent application (PCT/EP2024/078043) for "STING ANTAGONIST COMPOUNDS" on Oct 04, 2024. With publication no. WO/2025/073956, the details related to the patent application was published on Apr 10, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SENSFUSS, Ulrich (2720 Vanlose), BETHELL, Richard Charles (11230 Stockholm)
Abstract:
The present invention relates to STING antagonists comprising a benzimidazole structure, which can be used to treat diseases or conditions associated with overactivation of STI...